DECIBEL THERAPEUTICS INC's ticker is DBTX and the CUSIP is 24343R106. A total of 41 filers reported holding DECIBEL THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $157,696 | +27.5% | 40,960 | 0.0% | 0.00% | – |
| Q1 2023 | $123,699 | -14.2% | 40,960 | -41.8% | 0.00% | – |
| Q4 2022 | $144,156 | +144.3% | 70,320 | +309.8% | 0.00% | – |
| Q3 2022 | $59,000 | -18.1% | 17,160 | 0.0% | 0.00% | – |
| Q2 2022 | $72,000 | +46.9% | 17,160 | +5.5% | 0.00% | – |
| Q1 2022 | $49,000 | -32.9% | 16,260 | +3.6% | 0.00% | – |
| Q4 2021 | $73,000 | -39.7% | 15,700 | 0.0% | 0.00% | – |
| Q3 2021 | $121,000 | -81.7% | 15,700 | -73.0% | 0.00% | – |
| Q1 2021 | $661,000 | – | 58,218 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,139,685 | $27,001,000 | 4.71% |
| Samsara BioCapital, LLC | 826,422 | $7,107,000 | 0.88% |
| Orbimed Advisors | 4,945,192 | $42,529,000 | 0.43% |
| Foresite Capital Management IV, LLC | 297,711 | $2,560,000 | 0.35% |
| Alphabet Inc. | 1,636,258 | $14,072,000 | 0.29% |
| Casdin Capital, LLC | 1,171,421 | $10,074,000 | 0.26% |
| HARVARD MANAGEMENT CO INC | 328,798 | $2,828,000 | 0.16% |
| Tibra Equities Europe Ltd | 43,400 | $373,000 | 0.12% |
| AlphaCentric Advisors LLC | 45,000 | $387,000 | 0.10% |
| Bronte Capital Management Pty Ltd. | 159,462 | $1,371,000 | 0.10% |